Enhancing functional antibody responses against HIV envelope V1V2 through vaccine formulations.
Saved in:
| Title: | Enhancing functional antibody responses against HIV envelope V1V2 through vaccine formulations. |
|---|---|
| Authors: | Yengo CK; James J. Peters VA Medical Center, Bronx, NY, United States.; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Liu X; James J. Peters VA Medical Center, Bronx, NY, United States.; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Laghlali G; Department of Microbiology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Department of Pharmaceutics, Ghent University, Ghent, Belgium., Park SC; Department of Microbiology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Klingler J; James J. Peters VA Medical Center, Bronx, NY, United States.; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Luo CC; Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY, United States., Jiang X; Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY, United States., Kong XP; Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY, United States., Rao PG; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Upadhyay C; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Wiest MJ; Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, United States.; Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan Medical School, Ann Arbor, MI, United States., Muramatsu H; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States., De Geest BG; Department of Pharmaceutics, Ghent University, Ghent, Belgium., Wong PT; Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, United States.; Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan Medical School, Ann Arbor, MI, United States.; Department of Biomedical Engineering, University of Michigan Medical School, Ann Arbor, MI, United States., Tam Y; Acuitas Therapeutics, Vancouver, BC, Canada., Pardi N; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States., Schotsaert M; Department of Microbiology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Icahn Genomics Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Hioe CE; James J. Peters VA Medical Center, Bronx, NY, United States.; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Dec 08; Vol. 16, pp. 1722596. Date of Electronic Publication: 2025 Dec 08 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2025.1722596 |
